neoadjuvant endocrine therapy
1 product
2 abstracts
2 targets
Target
Estrogen ReceptorTarget
progesterone receptorAbstract
Clinical significance of circulating tumor DNA in neoadjuvant-treated HER2-negative luminal B breast cancer.Org: Genecast Biotechnology Co., Ltd, Beijing, China,
Abstract
Neoadjuvant endocrine therapy for early-stage breast cancer: An institutional experience during the COVID19 pandemic.Org: Dartmouth-Hitchcock Medical Center, Dartmouth College Geisel School of Medicine, Dartmouth Geisel Medical School Community and Family Medicine,